Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tanja A. Stief"'
Autor:
Theresa Kaeuferle, Tanja A Stief, Stefan Canzar, Nayad N Kutlu, Semjon Willier, Dana Stenger, Paulina Ferrada‐Ernst, Nicola Habjan, Annika E Peters, Dirk H Busch, Tobias Feuchtinger
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 1, Pp n/a-n/a (2022)
Abstract Objectives Exploiting the forces of human T cells for treatment has led to the current paradigm of emerging immunotherapy strategies. Genetic engineering of the T‐cell receptor (TCR) redirects specificity, ablates alloreactivity and brings
Externí odkaz:
https://doaj.org/article/ab8c3e6d149d403c8001e8a0cca41eae
Autor:
Tanja A. Stief, Tobias Feuchtinger, Dirk H. Busch, Judith Feucht, Lena M. Jablonowski, Michaela Döring, Franziska Blaeschke, Kilian Schober, Semjon Willier, T. Müller, Rupert Handgretinger, Theresa Kaeuferle, Peter Lang, Kevin M. Dennehy
Publikováno v:
Mol Ther
Viral infections cause life-threatening disease in immunocompromised patients and especially following transplantation. T cell receptor (TCR) engineering redirects specificity and can bring significant progress to emerging adoptive T cell transfer (A
Autor:
Tobias Feuchtinger, Larissa Deisenberger, Theresa Kaeuferle, Tanja A. Stief, Semjon Willier, Lena M. Jablonowski, Franziska Blaeschke
Publikováno v:
Mol Ther
Immunosuppression posttransplantation exposes patients to an increased risk for refractory viral infections as an important cause of morbidity and mortality. Protective T cell immunity can be restored by adoptive T cell transfer, but ongoing immunosu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::308bfb292317bc8e2bb679f0987bce61
https://europepmc.org/articles/PMC7474265/
https://europepmc.org/articles/PMC7474265/
Autor:
Tobias Feuchtinger, Kilian Schober, Theresa Kaeuferle, Ramin Lotfi, Tanja A. Stief, Sebastian Kobold, Beate Wagner, Dana Stenger, Felicitas Rataj, Irmela Jeremias, Franziska Blaeschke, Binje Vick, Semjon Willier, Thomas G. P. Grunewald, Dirk H. Busch
Publikováno v:
Blood
Blood 136, 1407-1418 (2020)
Blood 136, 1407-1418 (2020)
Anti-CD19 chimeric antigen receptor (CAR) T cells showed significant antileukemic activity in B-precursor acute lymphoblastic leukemia (ALL). Allogeneic, HLA-mismatched off-the-shelf third-party donors may offer ideal fitness of the effector cells, b